"Founded in 1922 and staffed by more than 700 physicians, the 306-bed St. Francis—New York's only specialty designated cardiac center—was again top-ranked on Long Island by U.S. News & World Report and, for the 11th consecutive year, listed among the Best Hospitals in America (2017–2018), in addition to being among just 7% of U.S. hospitals to have earned Magnet® designation."

During the past decade, St. Francis Hospital conducted 70 clinical trials. In the 10-year time frame, 70 clinical trials started and 36 clinical trials were completed, i.e. on average, 51.4% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 20 clinical trials were completed. i.e. 69% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Francis Hospital" #1 sponsor was "Abbott Medical Devices" with 18 trials, followed by "Medtronic Cardiovascular" with 9 trials sponsored, "St. Francis Hospital, New York" with 9 trials sponsored, "Boston Scientific Corporation" with 7 trials sponsored and "Edwards Lifesciences" with 7 trials sponsored. Other sponsors include 52 different institutions and companies that sponsored additional 50 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Francis Hospital" #1 collaborator was "Cardiovascular Research Foundation, New York" with 3 trials as a collaborator, "AT&T" with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Akiko Maehara, MD" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "St. Francis Hospital" are "Coronary Artery Disease" (24 trials), "Heart Failure" (9 trials), "Coronary Stenosis" (6 trials), "Mitral Regurgitation" (5 trials) and "Mitral Valve Regurgitation" (5 trials). Many other conditions were trialed in "St. Francis Hospital" in a lesser frequency.

Most popular intervention types in "St. Francis Hospital" are "Device" (70 trials), "Drug" (22 trials), "Procedure" (12 trials), "Other" (10 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)" (4 trials), "Control" (2 trials), "Coronary PCI guided by Angiography" (2 trials), "Coronary PCI guided by OCT" (2 trials) and "Dapagliflozin matching placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "St. Francis Hospital" are 105 trials for "All" genders.

Currently, there are NaN active trials in "St. Francis Hospital". undefined are not yet recruiting, 25 are recruiting, 14 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 51 completed trials in St. Francis Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in St. Francis Hospital, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 60 trials that are defined as “Not Applicable".

St. Francis Hospital has several departments that took part in Clinical trials: "Cancer Institute at Saint Francis Hospital" - 26 trials, "Cardiac Arrhythmia & Pacemaker Center" - 2 trials, "Cardiac Arrhythmia and Pacemaker Center" - 2 trials, "St. Francis Hospital & Heart Center" - 2 trials